- Home
- AMED vs RXRX Comparison
AMED vs RXRX Comparison
Compare AMED & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMED
- RXRX
- Stock Information
- Founded
- AMED 1982
- RXRX 2013
- Country
- AMED United States
- RXRX United States
- Employees
- AMED N/A
- RXRX N/A
- Industry
- AMED Medical/Nursing Services
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- AMED Health Care
- RXRX Health Care
- Exchange
- AMED Nasdaq
- RXRX Nasdaq
- Market Cap
- AMED 3.0B
- RXRX 2.6B
- IPO Year
- AMED N/A
- RXRX 2021
- Fundamental
- Price
- AMED $91.89
- RXRX $4.24
- Analyst Decision
- AMED Hold
- RXRX Buy
- Analyst Count
- AMED 5
- RXRX 4
- Target Price
- AMED $101.00
- RXRX $8.25
- AVG Volume (30 Days)
- AMED 324.0K
- RXRX 16.9M
- Earning Date
- AMED 04-23-2025
- RXRX 05-08-2025
- Dividend Yield
- AMED N/A
- RXRX N/A
- EPS Growth
- AMED N/A
- RXRX N/A
- EPS
- AMED 1.31
- RXRX N/A
- Revenue
- AMED $2,348,324,000.00
- RXRX $58,839,000.00
- Revenue This Year
- AMED $6.54
- RXRX $72.81
- Revenue Next Year
- AMED $5.32
- RXRX $51.04
- P/E Ratio
- AMED $70.98
- RXRX N/A
- Revenue Growth
- AMED 5.00
- RXRX 32.00
- 52 Week Low
- AMED $82.15
- RXRX $4.06
- 52 Week High
- AMED $98.95
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- AMED 42.52
- RXRX 27.30
- Support Level
- AMED $91.48
- RXRX $6.27
- Resistance Level
- AMED $93.25
- RXRX $5.37
- Average True Range (ATR)
- AMED 0.81
- RXRX 0.37
- MACD
- AMED -0.05
- RXRX -0.15
- Stochastic Oscillator
- AMED 29.53
- RXRX 6.25
Stock Price Comparison Chart: AMED vs RXRX
About AMED Amedisys Inc
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.